Kudos on your EXCELLENT synopsis of that clinical-level paper Hanuman! Your level sharing of knowledge in term descriptions and professional expertise in therapeutic and recovery fields are appreciated.
I expect or at least hope this has attracted the eyes of the international Pharma companies. Needing some institutional investing firms to climb on now.
Nuts Hanuman, Nameste' we just gotta deal with this.
8-K Just hit EDGAR, ahhh, we're about to see a dive in after hours. Peace be with ALL.[/quote]........Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On September 15, 2020, Ben R. Taylor gave notice of his resignation from his position as President and Chief Financial Officer of TYME for personal reasons, primarily his family’s relocation. Mr. Taylor’s resignation will be effective September 30, 2020, after which time he will serve in a consulting role with the Company until November 30, 2020. TYME’s management thanks Mr. Taylor for his many contributions to the Company and wishes him well.
In his consulting role, Mr. Taylor will provide certain financing and strategic consulting services to the Company. He will receive $30,000 per month in compensation for such services.[/quote]Here's a link, should get you to the 8K form.
News 
Market Data 
Discover 
